Team Member

Johanna Siehler
PhD student

Phone: + 49 89-3187-49643
Building/Room: Campus Neuherberg, building 3620, room 020b


Project description

Type 2 diabetes is characterized by reduced sensitivity of the insulin receptor and by ß-cell dysfunction. We have identified a novel receptor, which modulates insulin receptor signaling and could be targeted in Type 2 diabetes. My project focuses on the investigation of this novel receptor during the differentiation of human induced pluripotent stem cells towards ß-cells. This human in vitro system allows for human translation. Furthermore, ß-cell development can be investigated since the differentiation protocol recapitulates the steps of embryonic development.


Academic and Research Activities

Since March 2018                       PhD student at Helmholtz Zentrum München, Institute of Diabetes and Regeneration Research, Munich, Germany

March 2017 – March 2018          University of Würzburg, Chair for Drug Formulation and Delivery

Oct. 2013 – Dec. 2016                 Master of Science in Molecular Medicine, University of Freiburg

Oct. 2010 – Aug. 2013                 Bachelor of Science in Molecular Medicine, University of Freiburg

We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.